HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 164 filers reported holding HEALTH CATALYST INC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,338,833 | +50.8% | 1,120,438 | +86.3% | 0.01% | +66.7% |
| Q2 2023 | $7,517,925 | +9.1% | 601,434 | +1.9% | 0.01% | 0.0% |
| Q1 2023 | $6,889,198 | +37.5% | 590,334 | +25.2% | 0.01% | +20.0% |
| Q4 2022 | $5,010,280 | +9.4% | 471,334 | -0.2% | 0.01% | +25.0% |
| Q3 2022 | $4,581,000 | +3.2% | 472,244 | +54.2% | 0.00% | 0.0% |
| Q2 2022 | $4,437,000 | -37.5% | 306,244 | +12.8% | 0.00% | -20.0% |
| Q1 2022 | $7,095,000 | -25.5% | 271,527 | +13.0% | 0.01% | -28.6% |
| Q4 2021 | $9,518,000 | -18.3% | 240,244 | +3.1% | 0.01% | -12.5% |
| Q3 2021 | $11,648,000 | -9.9% | 232,909 | -0.0% | 0.01% | -11.1% |
| Q2 2021 | $12,935,000 | +24.6% | 233,015 | +5.0% | 0.01% | +28.6% |
| Q1 2021 | $10,384,000 | +136.4% | 222,015 | +120.0% | 0.01% | +133.3% |
| Q4 2020 | $4,393,000 | +84.9% | 100,909 | +55.5% | 0.00% | +50.0% |
| Q3 2020 | $2,376,000 | +81.4% | 64,909 | +44.5% | 0.00% | +100.0% |
| Q2 2020 | $1,310,000 | – | 44,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 852,504 | $8,269,000 | 11.18% |
| Nepsis Inc. | 826,841 | $8,020,000 | 2.90% |
| First Light Asset Management, LLC | 1,149,833 | $11,153,000 | 1.13% |
| Bullseye Asset Management LLC | 55,434 | $538,000 | 0.31% |
| Portolan Capital Management | 303,602 | $2,945,000 | 0.31% |
| CVS HEALTH Corp | 32,273 | $313,000 | 0.30% |
| Rock Springs Capital Management LP | 880,000 | $8,536,000 | 0.22% |
| Granahan Investment Management | 648,299 | $6,289,000 | 0.20% |
| Bares Capital Management | 452,400 | $4,388,000 | 0.17% |
| Rhenman & Partners Asset Management AB | 180,000 | $1,588,000 | 0.17% |